M&A: Page 3


  • Image attribution tooltip
    Maks_Lab via Getty Images

    Medtech M&A falls 85% but activity could rebound in second half: report

    PwC highlights a range of barriers that could stop acquisitions, including supply chain issues, scrutiny from the Federal Trade Commission and geopolitical concerns.

    By June 24, 2022
  • A stock image of a calculator alongside financial numbers
    Image attribution tooltip
    atiatiati via Getty Images

    Bioventus agrees to staggered payment plan to close stalled $315M CartiHeal takeover

    Rising interest rates quashed a plan for Bioventus to fund the takeover of the joint repair company with a bond offering. Now, the deal will get much more expensive, J.P. Morgan analysts said.

    By June 23, 2022
  • Intuitive Surgical da Vinci robot, surgeon at surgeon console Explore the Trendline
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Trendline

    More mergers, new diabetes devices and the road to MDR: Medtech trends in 2023

    Medical device leaders expect financial pressures to ease as companies navigate regulatory changes in Europe, planned spinoffs and product launches.

    By MedTech Dive staff
  • Boston Scientific inks $230M deal to buy majority stake in M.I.Tech

    M.I.Tech is a South Korean manufacturer of endoscopic and urologic medical devices. Analysts at BTIG said the deal complements Boston Scientific’s non-vascular stent portfolio and boosts its international presence.

    By June 16, 2022
  • ResMed to acquire German health software company MediFox for $1B

    The acquisition continues a pattern of medical device companies buying software platforms. ResMed expects the deal to close by the end of the year.

    By Ricky Zipp • June 14, 2022
  • Oracle closes $28B buy of 'huge growth engine' Cerner

    With the deal’s close, the days of standalone EHR vendors are increasingly in the rearview mirror.

    By Rebecca Pifer • June 10, 2022
  • Becton Dickinson's headquarters, viewed from overhead, are surrounded by a green lawn.
    Image attribution tooltip
    Permission granted by Becton Dickinson

    BD to acquire Parata for $1.53B as part of strategy to boost margins

    The deal is expected to help Becton Dickinson reach its goal of a 25% operating margin by the end of 2025. J.P. Morgan analysts said it would be the most meaningful tuck-in deal since BD acquired Bard in 2017. 

    By June 7, 2022
  • Boston Scientific Watchman FLX left atrial appendage closure device
    Image attribution tooltip
    Courtesy of Boston Scientific

    Boston Scientific would be 'good fit' for increasingly acquisitive J&J, analysts say

    A limited portfolio overlap could make Boston Scientific a target should Johnson & Johnson's CEO seek a large medtech acquisition.

    By May 31, 2022
  • A view of Baxter International's production facility in the state of North-Rhine Wetsphalia on January 15, 2021 in Halle, Germany.
    Image attribution tooltip
    Sascha Schuermann via Getty Images

    Baxter raises forecasts for Hillrom synergies, allaying concerns over $10.5B takeover

    Company executives said the additional cost savings emerged as they took a closer look at Hillrom’s real estate footprint.

    By May 26, 2022
  • FTC
    Image attribution tooltip
    Carol Highsmith. (2005). "Apex Bldg." [Photo]. Retrieved from Wikimedia Commons.

    Medtronic completes Intersect acquisition following FTC order

    The Federal Trade Commission required Medtronic to divest a subsidiary of Intersect ENT to complete the deal. Medtronic announced the $1.1 billion acquisition last August.

    By Updated May 16, 2022
  • $100 bills floating
    Image attribution tooltip
    choness via Getty Images

    Digital health funding dropped in Q1 to lowest level since 2020: CB Insights

    The report is directionally in line with the findings of an earlier report from Rock Health, which described how the drying up of deals in February and March may be an early sign of a correction in digital health venture capital funding.

    By April 14, 2022
  • Image attribution tooltip
    E+ via Getty Images

    'Interesting anomaly': Hospital M&A fell to record low in Q1

    Hospital M&A activity in the first quarter bucked last year's trends as both the amount and size of deals shrank, according to Kaufman Hall.

    By Hailey Mensik • April 11, 2022
  • Illumina sues Guardant CEOs over trade secrets, sparking counterblast against 'retaliatory' lawsuit

    Guardant called the lawsuit "frivolous and retaliatory" and framed it as a response to its concerns about the Illumina-Grail merger.

    By March 18, 2022
  • A child plays EndeavorRx on a tablet. The digital therapeutic intended to improve attention in kids with ADHD.
    Image attribution tooltip
    Permission granted by Akili Interactive

    Akili plans to go public as it prepares to market video game treatment

    "We've proven that foundation and now it's time to run and scale," CEO Eddie Martucci told MedTech Dive. The company is going public through a $1 billion SPAC, rather than a traditional IPO, which it expects to close in mid-2022.   

    By March 10, 2022
  • DOJ moves forward with suit to block UnitedHealth's acquisition of Change

    The lawsuit alleges that if UnitedHealth acquired Change, the payer would be able to gain a competitive advantage by seeing "very competitively sensitive" data from other insurers.

    By Shannon Muchmore • Feb. 25, 2022
  • Johnson & Johnson's campus in Irvine, California
    Image attribution tooltip
    Mario Tama via Getty Images

    What does a more aggressive M&A approach mean for J&J's devices unit?

    After medical device deals took off last year, one of the industry's biggest companies could make a splash in the sector in 2022.

    By Ricky Zipp , Feb. 22, 2022
  • Closeup shot of two unrecognisable businesspeople shaking hands in an office
    Image attribution tooltip
    Delmaine Donson via Getty Images

    Diagnostics M&A expected to be strong in 2022 after dealmaking took off last year

    Respondents to KPMG's survey predict that deal volumes and values for the diagnostics space will jump again this year as companies are ready to spend more of their COVID-19 cash.

    By Feb. 16, 2022
  • Johnson & Johnson, credo wall
    Image attribution tooltip
    Permission granted by Johnson & Johnson

    J&J's DePuy Synthes buys ortho company CrossRoads Extremity Systems

    The deal, for an undisclosed amount, comes just weeks after Johnson & Johnson executives said the company will have a more aggressive M&A strategy going forward for the pharmaceutical and medical devices businesses.

    By Ricky Zipp • Feb. 10, 2022
  • An empty hospital operating theater is prepared with lighting and equipment
    Image attribution tooltip
    JohnnyGreig via Getty Images

    Healthcare staffing shortages a 'rising concern' for medtechs: Moody's

    In a recent quarterly report, Moody's Investors Service called out hospital labor shortages as having a potential material impact on procedures in 2022, even as the omicron surge begins to decline.

    By Feb. 9, 2022
  • Image attribution tooltip
    alvarez via Getty Images
    Deep Dive

    4 key trends for procedure-reliant medtechs in 2022

    Medical device companies likely will face the same challenges this year that they have been dealing with since the pandemic's start, such as procedure volatility and hospital staffing shortages.

    By Ricky Zipp • Jan. 27, 2022
  • Image attribution tooltip
    Mario Tama via Getty Images

    J&J's device recovery slowed by omicron surge, with impact expected over next several months

    CFO Joseph Wolk said that the medtech giant expects pressure from COVID-19 and hospital staffing shortages to continue through the first half of 2022, with businesses recovering month by month.

    By Ricky Zipp • Jan. 25, 2022
  • $100 bills floating
    Image attribution tooltip
    choness via Getty Images

    Medtech M&A, IPOs hit new highs as more buyers enter the space: SVB

    In a new report, Silicon Valley Bank projects that medical device mergers and acquisitions "will stay hot, as a diverse set of acquirers compete for the top deals," but sees a slowdown in initial public offering activity.

    By Jan. 14, 2022
  • A building in front of a lake with the words 'Medtronic' on a sign.
    Image attribution tooltip
    Medtronic

    Medtronic CEO: Company on track to hit guidance, omicron impact 'uncertain'

    Geoff Martha, who spoke on the opening day of J.P. Morgan's healthcare conference, said the medtech is being impacted by both the delta and omicron variants, including ongoing pressure from hospital staffing shortages.

    By Ricky Zipp • Jan. 10, 2022
  • Wall Street backs Stryker-Vocera strategic fit but split on valuation

    The nearly $3 billion buy values Vocera at about 11.5 times higher than expected 2022 revenue, leading some analysts to question the overall price.

    By Ricky Zipp • Updated Jan. 7, 2022
  • The concept of the word M&A on cubes on a beautiful green background. Business concept
    Image attribution tooltip
    Zhanna Hapanovich via Getty Images

    Medtech's biggest deals in 2021 and what to expect next

    After dealmaking took off last year following a 2020 lull, market watchers anticipate robust M&A ahead in 2022 as companies pursue faster growth and greater scale. 

    By Jan. 4, 2022
  • Image attribution tooltip
    Permission granted by Quidel Corporation

    Quidel to buy Ortho Clinical Diagnostics in $6B deal; stock tanks

    CEO Doug Bryant said the combined company will have a "broader geographic footprint" thanks to Ortho's reach across 130-plus countries. Quidel's shares fell by as much as 17.8% in Thursday morning trading.

    By Dec. 23, 2021